The majority of patients in your practice experience reduced visual acuity and symptoms due to eye misalignment. Even small misalignments can cause poor vision and painful symptoms, and even small prism corrections can provide dramatic results. Historically, however, measuring small amounts of prism has been all but impossible.
But the future of prism is now!
The Neurolens Measurement Device, Gen 2—or NMD2—is an objective, accurate and repeatable way to measure eye misalignment as small as 0.01 Prism Diopters. The diagnostic information from the NMD2 is used to prescribe Neurolenses with patented contoured prism technology, which bring the eyes into alignment, relieving symptoms like headaches and eye strain for 93% of wearers.
Learn more about becoming a Neurolens provider at neurolens.com and join the new standard of care providing dramatic patient outcomes and practice success.